SEATTLE – The U.S. government was to announce on Thursday that it will allow more research into marijuana but has rejected requests to relax the classification of the substance as a dangerous drug with no medical use, sources with direct knowledge of the matter said.
The decision is the Drug Enforcement Administration’s response to a 2011 petition by two former state governors who had urged federal agencies to re-classify marijuana as a drug with accepted medical uses, the two sources said on Wednesday. They requested anonymity because they were not authorized to publicly discuss the matter.
The DEA declined to comment. But earlier on Wednesday, the agency had sent emails, a copy of which was reviewed by Reuters, to parties which had expressed an interest in the matter, saying it would be making “important announcements regarding marijuana related topics” on Thursday.
The Food and Drug Administration did not immediately respond to requests for comment.
For decades, marijuana has been classified as a “Schedule I” drug with “no currently accepted medical use and a high potential for abuse,” on par with heroin. The government has repeatedly rejected appeals over the years to reclassify marijuana. Loosening that definition could encourage scientific study of a drug that is being used to treat diseases in several U.S. states despite little proof of its effectiveness.
Twenty-five states have sanctioned some forms of marijuana use for medical purposes. Four states — Alaska, Washington, Oregon, and Colorado — and the District of Columbia have gone even further, allowing its recreational use for adults.
California and eight other states have recreational or medical marijuana proposals headed for their 2016 ballots.
A drug can be reclassified through congressional legislation or a formal scheduling petition process that involves medical and scientific evaluation by the FDA and DEA.
The DEA only allows marijuana for federally sanctioned research to be cultivated at a garden at the University of Mississippi, an operation overseen by the National Institute on Drug Abuse.
Dope advocates have long argued that this arrangement, and the labeling of marijuana as among “the most dangerous drugs” under the Controlled Substances Act, has sharply limited the supply available for research.
The sources said the federal government on Thursday would pave the way for increased research, possibly with marijuana supplies from outside the University of Mississippi.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.